DAWN Overview
Upcoming Projects (DAWN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (DAWN)
-
Discussing the data from the registrational Phase 2 FIREFLY-1 trial evaluating the investigational agent tovorafenib from Day One Bio in Low-Grade Glioma and Advance Solid Tumors
Ticker: DAWN
Executed On: Jun 20, 2023 at 08:00 AM EDT -
Discussing Day One Bio’s Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma following Pivotal Phase 2 data results
Tickers: DAWN, CMRX
Executed On: Jan 25, 2023 at 03:00 PM EST
Upcoming & Overdue Catalysts (DAWN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (DAWN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!